Esophagitis: all 324 studies
Page 3 of 4. Open to participants first (37), then studies with results posted, then the rest; newest registration first within each.
- EoE Food DesensitizationWithdrawnNCT02881372Not applicable
- Eosinophil β1 Integrin Activation as a Biomarker for Eosinophilic EsophagitisCompletedNCT02775045
- Treatment Effect Between Dexlansoprazole and Double-dose Lansoprazole in Obesity Patients With Reflux EsophagitisStatus unknownNCT02759393Phase 4
- A Study to Evaluate REbamiPide as an Adjuvant Regimen to Heal erosIve Reflux EsophagitisCompletedNCT02755753Phase 4
- Study of Epigallocatechin-3-gallate (EGCG) for Esophagus Protection in Patients With Lung Cancer Receiving Radial RadiotherapyStatus unknownNCT02577393Phase 2
- The Effects of Whole Food Intervention on Mucositis in Patients Treated for Thoracic CancerTerminatedNCT02575391Phase 1/2
- a4b7 Integrin in Eosinophilic EsophagitisCompletedNCT02546219
- Maintenance of Remission With Budesonide Orodispersible Tablets vs. Placebo in Eosinophilic EsophagitisCompletedNCT02493335Phase 3
- Nexium Capsules S-CEI for Justification of Esomeprazole in Acid Related Disease for Reflux Symptom Healing Based on Patient Clinical OutcomesCompletedNCT02477475
- To Evaluate Efficacy and Safety of Z-215 in Erosive EsophagitisCompletedNCT02463643Phase 2
- Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Erosive EsophagitisCompletedNCT02456935Phase 3
- WEI NASAL JET for The Sedation of Outpatient Upper Gastrointestinal EndoscopyStatus unknownNCT02436018Not applicable
- Food Antigen in Eosinophilic EsophagitisCompletedNCT02434705
- Budesonide Orodispersible Tablet vs. Placebo in Active Eosinophilic EsophagitisCompletedNCT02434029Phase 3
- EndoFLIP Use in Upper GI Tract StenosisTerminatedNCT02354716
- The Effect of Sucralfate Slurry in Patients With Eosinophilic EsophagitisCompletedNCT02353078Early Phase 1
- Esophageal Motility in Eosinophilic Esophagitis Evaluated by High Resolution Manometry.Status unknownNCT02331849Not applicable
- Mucosal Impedance in Pediatric PopulationCompletedNCT02320981
- Esophageal Absorption in EoETerminatedNCT02314455Not applicable
- Double Tract Anastomosis and Gastric Tube Anastomosis to Proximal GastrectomyTerminatedNCT02288728Not applicable
- Budesonide Effervescent Tablets vs. Viscous Budesonide Suspension vs. Placebo in Eosinophilic EsophagitisCompletedNCT02280616Phase 2
- Prevalence of Eosinophilic Esophagitis in Children With Celiac DiseaseCompletedNCT02190513
- TAK-438 - Safety, Blood Levels & Effects of Repeated DosesCompletedNCT02141711Phase 1
- Mometasone-furoate for Treatment of Eosinophilic Esophagitis - a Randomized Placebo Controlled Study.TerminatedNCT02113267Phase 2
- Dose Ranging Study of RPC4046 in Eosinophilic EsophagitisCompletedNCT02098473Phase 2
- Improved Diagnostics of Celiac Disease in ChildrenCompletedNCT02072590
- Resolving Bile Reflux by Lanreotide in Patients With Roux-en-Y GastrojejunostomyStatus unknownNCT02054637Phase 2
- Assessment of GERD Knowledge Level Among Patients With it in KoreaStatus unknownNCT02049723
- Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Erosive EsophagitisCompletedNCT02028663Phase 2
- EoE(Eosinophilic Esophagitis)CompletedNCT01999439Not applicable
- Risk Factors and Biomarkers for Diagnosis and Treatment of EoECompletedNCT01988285
- Adverse Events During Upper Gastrointestinal EndoscopyStatus unknownNCT01979549
- BE Study Between a Capsule and a Sachet Formulation of D961H by Pharmacodynamics in Japanese Healthy Male SubjectsCompletedNCT01964131Phase 1
- Nasal Nitric Oxide Levels in Eosinophilic Esophagitis (EoE)CompletedNCT01929824
- Assessing Risk of Food Insecurity Within Households of Children With Food AllergyCompletedNCT01897506
- Proton Pump Inhibitor (PPI) Responsive Eosinophilic Esophagitis EoE: Gastroesophageal Reflux Disease (GERD) or Eosinophilic Esophagitis (EoE)?CompletedNCT01865825
- The Study to Evaluate Efficacy and Safety of Newrabell® Tab.(Rabeprazole Sodium) 10mg b.i.d in Refractory GERDCompletedNCT01860482Phase 4
- Dietetic Versus Topical Steroids for Pediatric Eosinophilic EsophagitisCompletedNCT01846962Phase 4
- CYP2C19 Genotype Predictor of Gastric Acid SuppressionWithdrawnNCT01824199Early Phase 1
- Sirolimus for Eosinophil-Associated Gastrointestinal DisordersTerminatedNCT01814059Phase 1
- The Effect of Caphosol® on the Development of Esophagitis in (N)SCLC Patients Treated With Concurrent Chemo/RadiotherapyTerminatedNCT01809756Not applicable
- Eosinophilic Gastrointestinal Disorders Patient RegistryWithdrawnNCT01779154
- Minimal Change Esophagitis by i-Scan Endoscopy in Dyspeptic PatientsCompletedNCT01742377
- The Role of HIF-2a in the Pathogenesis of Reflux EsophagitisCompletedNCT01733810Not applicable
- Eosinophilic Esophagitis Treatment: Montelukast vs FluticasoneWithdrawnNCT01702701Phase 3
- Domperidone in Treating Patients With Gastrointestinal DisordersActive, not recruitingNCT01696734Phase 3
- Allergy Immunotherapy in the Management of Eosinophilic EsophagitisWithdrawnNCT01685034Not applicable
- Intestinal Permeability in Response to Treatment in Eosinophilic Esophagitis PatientsCompletedNCT01641913Phase 1
- Prevalence of Food Allergies in a Cohort of Adult Patients With Eosinophilic EsophagitisCompletedNCT01631591
- A Randomized, Double-Blind, Multicenter Study to Evaluate the Acid-inhibitory and Dose-response Efficacy of TAK-438 (20 mg, 40 mg) in Patients With Proton Pump Inhibitor (PPI) - Resistant Erosive EsophagitisCompletedNCT01630746Phase 3
- New Serological Markers for Eosinophilic EsophagitisStatus unknownNCT01624129
- Effect of Repeated Doses of YF476, Omeprazole and Placebo on Stomach Acidity in Healthy VolunteersCompletedNCT01599858Phase 1
- Effect of 5, 10 or 25 mg of YF476 Daily for 14 Days on Stomach Acidity in Healthy VolunteersCompletedNCT01597674Phase 1
- Nexium Capsules RE Maintenance Specific Clinical Experience InvestigationCompletedNCT01562639
- Adipokines and the Risk of Reflux EsophagitisStatus unknownNCT01560598
- Esophageal Monitoring Device for Assessing Mucosal ImpedanceCompletedNCT01556919
- Study to Investigate the Safety, Tolerability and Efficacy of YH4808 in Patients With Reflux EsophagitisCompletedNCT01538849Phase 2
- Effect of Single Doses of YF476 on Stomach Acidity Compared With Ranitidine and Placebo in Fasted and Fed StatesCompletedNCT01538797Phase 1
- Safety, Tolerability and Pharmacokinetics of Single Rising Doses of YF476, a Gastrin Antagonist, in Healthy MenCompletedNCT01538784Phase 1
- Analysis of GERD Symptoms Using Gastroesophageal Reflux Impact Score Questionnaire for Quality of LifeCompletedNCT01536080
- Efficacy Study of Ilaprazole to Treat Erosive EsophgitisCompletedNCT01509261Phase 3
- Unusual Clinical Findings of Herpes EsophagitisStatus unknownNCT01501526
- A Six Month, Safety Follow-up Study in Eosinophilic Esophagitis Subjects Who Completed Study PR-021CompletedNCT01498497
- Predictors of Proton Pump Inhibitor (PPI) Response in Eosinophilic EsophagitisWithdrawnNCT01479231Phase 1/2
- Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Maintenance Treatment of Healed Erosive EsophagitisCompletedNCT01459367Phase 3
- Long-Term Safety Study of TAK-438 in the Maintenance Treatment of Healed Erosive EsophagitisCompletedNCT01452776Phase 3
- Nexium Capsules Clinical Experience InvestigationCompletedNCT01434485
- Safety and Tolerability Study of Oral EUR-1100 to Treat Eosinophilic EsophagitisCompletedNCT01386112Phase 1/2
- Registry for Eosinophilic Gastrointestinal Disorders (REGID)CompletedNCT01382563
- The Efficacy of i-Scan for Detecting Reflux EsophagitisCompletedNCT01381991Not applicable
- Tepilta® Versus Oxetacaine, Antacids and PlaceboTerminatedNCT01336530Phase 3
- Eosinophilic Esophagitis DatabankCompletedNCT01323803
- Quality of Life in New Treatable Therapy as Rabeprazole Option for Refractory Reflux EsophagitisCompletedNCT01321567
- Incidence of Reflux Esophagitis After PancreaticoduodenectomyStatus unknownNCT01311908
- To Learn How Bone Structure and Bone Mass Change After Long-term PPI UseCompletedNCT01306799
- Confocal Laser Endomicroscopy in Patients With Eosinophilic EsophagitisCompletedNCT01234376
- Immunopathogenesis of Food Allergy and Eosinophilic Gastrointestinal DisordersTerminatedNCT01212016
- Biology in Patients With Reflux EsophagitisCompletedNCT01194323
- Exhaled Nitric Oxide as a Biomarker of Disease Activity in Eosinophilic EsophagitisCompletedNCT01170234
- Identifying Responders to Xolair (Omalizumab) Using Eosinophilic Esophagitis as a Disease ModelCompletedNCT01040598Phase 1
- Routine Screening for Eosinophilic Esophagitis in Patients Presenting With DysphagiaStatus unknownNCT01028235
- Efficacy and Safety of QAX576 in Patients With Eosinophilic EsophagitisCompletedNCT01022970Phase 2
- A Randomized Double Blind Placebo Controlled Study of the Effect of Swallowed Beclomethasone Dipropionate on Inflammatory Markers in Adult Patients With Eosinophilic EsophagitisCompletedNCT01016223Phase 1
- Detection of Minimal Change Esophagitis Using Confocal Laser EndomicroscopyTerminatedNCT00954070
- Development, Validation and Evaluation of an Adult and Pediatric Eosinophilic Esophagitis Activity IndexStatus unknownNCT00939263
- Diagnostic Value of Fecal Calprotectin in Disorders of the Upper Gastrointestinal TractCompletedNCT00920400
- The Clinical Significance of Minimal Change in Reflux Esophagitis Based on the Gastroesophageal Reflux Disease QuestionnaireCompletedNCT00901004
- Nissen and Gastroplasty in Gastroesophageal Reflux Disease (GERD)CompletedNCT00872755Phase 4
- Evaluation Study of a Management Strategy for Gastroesophageal Reflux Disease (GERD)CompletedNCT00842387
- Domperidone for Relief of Gastrointestinal DisordersTerminatedNCT00761254Not applicable
- Transient Receptor Potential Vanilloid One (TRPV1) Receptor Expression in Children With Retrosternal PainCompletedNCT00677378
- Eosinophilic Esophagitis: Influence of Dilation on Dysphagia and InflammationCompletedNCT00667524
- Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Comparison of the Remission Rates of Once Daily Treatment With Esomeprazole 20mg and Lansoprazole 15mg for 6 Months in Patients Whose EE Has Been HealedCompletedNCT00644735Phase 4
- A Multicenter, Randomized, Double Blind, Double Dummy, Parallel-Group Efficacy Study Comparing 8 Weeks of Treatment With Esomeprazole Magnesium (40mg qd) to Lansoprazole (30mg qd) for the Healing of Erosive Esophagitis in Patients With Moderate or Severe Erosive EsophagitisCompletedNCT00641602Phase 4
- Proton Pump Inhibitor (PPI) Therapy for Newly Diagnosed EsophagitisCompletedNCT00586963
- Comparison of Acid Reflux at Two Levels in the Esophagus Using the BRAVO CapsuleCompletedNCT00579410
- Off Label Use of Infliximab in Adult Patients With Severe Eosinophilic EsophagitisCompletedNCT00523354Phase 2
- Trial of Montelukast in Eosinophilic EsophagitisCompletedNCT00511316Phase 1
- Safety and Efficacy of Ilaprazole 5, 20 and 40 mg QD and Lansoprazole 30 mg QD on Healing of Erosive EsophagitisCompletedNCT00471094Phase 2
- Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy VolunteersCompletedNCT00284908Phase 1